Articles tagged with: Pancreas

International Clinical Trials Day 2018

Posted in General News Published by Bethan Warman 21 May 2018

International Clinical Trials Day 2018

International Clinical Trials Day is celebrated on 20th May each year in recognition of the clinical trials conducted around the world, which ensure that research from the laboratory can be translated into patient benefit. The progress that is continuing to be made in cancer research, resulting in cancer survival rates doubling in the last 40 years, would not be possible without the researchers, clinicians, nurses and, of course, patients that are involved in clinical trials each year.

Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science

Posted in General News, Grants & Awards Published by Bethan Warman 16 May 2018

Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science

Queen Mary University of London has appointed four research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Innovation’s Rutherford Fund. Two of the fellows include BCI’s Dr Kit Curtius and Dr Dayem Ullah.

Queen Mary’s new Rutherford Academy will be aligned to its research as a partner of the London substantive site of Health Data Research UK - a major new initiative to transform health through data science. Forty two of these prestigious fellowships were awarded following a rigorous national competition, resulting in four fellowships at Queen Mary out of a total of fourteen awarded to London universities.

London Pancreas Workshop 2018

Posted in General News, BCI Spotlight Articles, Events Published by Bethan Warman 11 May 2018

A forum for state-of-the-art clinical and basic research in pancreatic cancer

London Pancreas Workshop 2018

On Friday 4th May, BCI hosted the seventh London Pancreas Workshop, co-organised by Prof Hemant Kocher and our Director Prof Nick Lemoine, which attracted delegates from across Europe and America, with over 140 attendees in total. The biennial event is recognised as a forum for state-of-the-art clinical and basic research in pancreatic cancer.

The areas of focus for this year’s workshop were diagnostics, clinical trials and preclinical work for targeting pancreatic cancer. We heard a variety of interesting talks in these areas, delivered by researchers renowned in their fields.

UK charities join forces to fund the work of Dr Angus Cameron

Posted in General News, Grants & Awards Published by Bethan Warman 05 April 2018

Supporting vital research on pancreatic cancer

UK charities join forces to fund the work of Dr Angus Cameron

BCI’s Dr Angus Cameron, Centre for Tumour Biology, is to receive joint funding from Worldwide Cancer Research and Pancreatic Cancer Research Fund (PCRF) to support vital research on pancreatic cancer. The charities have awarded equal sums totalling £235,000 to support the work of Dr Cameron and his laboratory group.

Pancreatic cancer is diagnosed in approximately 9,900 individuals annually in the UK and, although this disease accounts for only 3% of the total cancer cases diagnosed each year in the UK, the prognosis is dismal- with less than 1% of patients surviving for 10 years or more.

Staying connected: New developments for tissue banking bioinformatics

Posted in General News, Publications Published by Bethan Warman 01 February 2018

Tissue banks are a valuable resource for scientists

Staying connected: New developments for tissue banking bioinformatics

A team of researchers at the Barts Cancer Institute (BCI) of Queen Mary University of London have developed new analytical tools to aid in the analysis of tissue bank (TB) samples, which are an extremely valuable resource for scientists.

Researchers use flu-like virus to attack pancreatic cancer

Posted in General News, Publications Published by Bethan Warman 25 January 2018

Researchers use flu-like virus to attack pancreatic cancer

A flu-like virus has now been used in experiments to successfully inhibit the growth of pancreatic cancer, according to an early study by researchers at the Barts Cancer Institute (BCI) of Queen Mary University of London (QMUL).

The study funded by the charity Pancreatic Cancer Research Fund, led by Dr Gunnel Halldén based at the Centre for Molecular Oncology, and including UK colleagues at Cardiff University, suggests that the new technique could potentially become a promising new treatment for patients with the aggressive disease, and could be combined with existing chemotherapy to improve chances of survival.

Steps towards the development of a new immunotherapy for pancreatic cancer

Posted in General News, Publications Published by Bethan Warman 23 January 2018

Steps towards the development of a new immunotherapy for pancreatic cancer

A research team led by Professor Yaohe Wang at the Barts Cancer Institute (BCI) of Queen Mary University of London (QMUL) has created a novel oncolytic viral agent expressing interleukin-12 (IL-12) that shows promise as a potential anti-tumour immunotherapy for the treatment of pancreatic cancer.

Using hamster models of pancreatic cancer that closely mimic the stages of tumour development in humans, the study demonstrated that treatment with the virus expressing a modified form of IL-12 could result in up to 100 per cent tumour eradication and survival.

Hugh Brasher and Pancreatic Cancer UK Visit the BCI

Posted in General News, Engagement Published by Reza Roozitalab 10 November 2017

November is Pancreatic Cancer Awareness Month #PCAM

Hugh Brasher and Pancreatic Cancer UK Visit the BCI

Hugh Brasher and members of the team from Pancreatic Cancer UK visited the BCI to learn about the latest research and what is being done to beat pancreatic cancer sooner.

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.